Aleppo, G.

Journal Article

Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes.

Diabetes Technology & Therapeutics. 2024

Comprehensive telehealth model to support diabetes self-management.

JAMA network open. 2023

Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes.

Diabetes Technology & Therapeutics. 2022

How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod® 5 System.

Diabetes Research and Clinical Practice. 2022

Real-world evidence supporting Tandem Control-IQ Hybrid Closed-Loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations.

Diabetes Technology & Therapeutics. 2022

Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): findings from the T1D exchange.

Journal of Diabetes and Its Complications. 2022

Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial.

JAMA. 2021

Lost in translation: a disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion.

Diabetes Technology & Therapeutics. 2021

Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes.

Diabetes care. 2021

The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin.

Diabetes care. 2021

Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring.

Journal of the Endocrine Society. 2020

Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial.

JAMA. 2020

. 2018;41:2275-2280.

Diabetes care. 2019

Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring.

Diabetes care. 2018

REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes.

Diabetes care. 2017

Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels.

Annals of Internal Medicine. 2017

Hypoglycemia in older adults with type 1 diabetes.

Diabetes Technology & Therapeutics. 2016

Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes.

Diabetes care. 2016

Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry.

Diabetes care. 2015

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.

Diabetes care. 2014

Conference Poster

Autonomic neuropathy in type 1 diabetes (T1D): findings from the T1D Exchange [poster]

2019

Review

Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking [review].

Diabetes Technology & Therapeutics. 2023

What's wrong with this picture? A critical review of current Centers for Medicare & Medicaid Services coverage criteria for continuous glucose monitoring [review].

Diabetes Technology & Therapeutics. 2021

The role of blood glucose monitoring in diabetes management [review]

2020

Abstract

Hypoglycemia and glucose variability in older adults with type 1 diabetes (T1D) [abstract 408-P].

Diabetes. 2015